← SynDRA
LEVOCETIRIZINE
SynDRA canonical compound SYN0023456 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Approval status | Approved · Rx/OTC |
| Primary target(s) | HRH1 |
| Mechanism of action | Histamine receptor antagonist |
| Indication | allergic rhinitis | urticaria |
| Disease area | allergy |
All known targets
Mechanisms of action (all sources)
- Histamine receptor antagonist
- HRH1 ANTAGONIST
- Histamine H1 receptor antagonist
Drug classes
- Histamine H1 Receptor Antagonists
- Histamine-1 Receptor Antagonist
- Histamine Agents
- Histamine Antagonists
- Histamine H1 Antagonists
- Histamine H1 Antagonists, Non-Sedating
- Neurotransmitter Agents
ATC classes
- R06A · ANTIHISTAMINES FOR SYSTEMIC USE
Cross-references
Synonyms
- levocetirizine hydrochloride
- xyzal
- levocetirizine dihydrochloride
- (R)-cetirizine
- levocetirizine HCl
- Levocetirizina
- Cetirizine (r)-form
- (-)-cetirizine
- (r)-cetirizine
- Cetirizine, (-)-
- Cetirizine, (r)-
- Xazal
- Xyzal
- (-)-Cetirizine
- Levocetirizine HCl
- (R)-2-(2-(4-((4-Chlorophenyl)(phenyl)methyl)piperazin-1-yl)ethoxy)acetic acid
- 6U5EA9RT2O
- Xarlin
- ACETIC ACID, (2-(4-((R)-(4-CHLOROPHENYL)PHENYLMETHYL)-1-PIPERAZINYL)ETHOXY)
- (2-{4-[(R)-(4-chlorophenyl)(phenyl)methyl]piperazin-1-yl}ethoxy)acetic acid
- 2-(2-{4-[(R)-(4-chlorophenyl)(phenyl)methyl]piperazin-1-yl}ethoxy)acetic acid
- SMR000466315
- UNII-6U5EA9RT2O
- Vozet
- R-levocetirizine
- Levocetirizine [USAN:INN:BAN]
- 2-[2-[4-[(R)-(4-chlorophenyl)-phenylmethyl]piperazin-1-yl]ethoxy]acetic acid
- Xazal (TN)
- Levocetirizine [INN]
- Cetirizine (-) isomer
- SCHEMBL4914
- Levocetirizine (USAN/INN)
- LEVOCETIRIZINE [USAN]
- MLS000759420
- MLS001401375
- BIDD:GT0791
- LEVOCETIRIZINE [VANDF]
- LEVOCETIRIZINE [MART.]
Reported adverse events
- Fatigue
- Somnolence
- Epistaxis
- Pyrexia
- Vomiting
- Nasopharyngitis
- Pharyngitis
- Gastrointestinal disorder
- Pregnancy
Look up LEVOCETIRIZINE in the interactive SynDRA portal →